The Genomic Applications Partnership Program (GAPP) funds downstream research and development (R&D) projects driven by challenges and opportunities identified by end-users. End-users are broadly described as stakeholders interested in using the results of genomics research from academia and implementing innovations into the market for either commercialization or public-good purposes. Examples could include industrial companies, industry consortia, government departments or other not-for-profit organizations. Past examples of funded GAPP projects and partnerships can be found in Genome Canada's database of previously funded projects
Promote the application and commercialization of genomics-derived solutions to address key sector challenges and opportunities.
- De-risk follow-on investment from public and private partners.
- Increase the socio-economic impact and profitability of genomics research by accelerating its translation to the application.
Genome Canada will provide support for projects ranging in size from $300,000 to $6 million in the total project budget. Investment from Genome Canada must not exceed 1/3 of the total investment in the project ($2 million), with the remaining. The remaining 2/3 must be secured through co-funding with at least 1/3 provided by the end-user (including cash or in-kind contributions for salary, travel, consumables, etc.).
- Project duration range between a minimum of six months to a maximum of three years.
- Additional details can be found in the GAPP Investment Strategy and Guidelines.
All projects must meet the following requirements:
- Develop and apply a genomics-derive tool, product or process to a challenge identified by end-users.
- Focus on later stage R & D, which will position the innovation for near-term implementation or commercialization, following the project's conclusion.
- Be co-led by an academic and end-user organization. Both partners must be actively engaged throughout the project.
- Demonstrate the potential to have a significant social and economic benefit to Canada.
The GAPP program consists of a three-stage gated application process:
- Expression of Interest (EOI)
- Project Pitch
- Supplementary Proposal
Expressions of Interest are reviewed on a rolling basis by Genome Canada. However, guideline dates for submission are outlined below. The complete application process generally takes approximately six months from EOI submission to funding decision.
Genome Alberta will be the conduit for submitting documents to the competition. In addition, Genome Alberta will help applicants navigate the various stages of proposal development to increase the competitiveness of their projects. Therefore, all potential applicants are encouraged to get in touch with Genome Alberta early to navigate GAPP proposal submission.
For all questions on the GAPP program, including copies of the current competition forms, please contact, Ryan Mercer
, Manager of Programs and Business Development.